Blue Buffalo sets $3M fundraising goal to fight pet cancerMay 31, 2018Six million dogs and nearly the same number of cats are affected by cancer each year. Despite the huge impact of the disease, consumer surveys indicate that eight in 10 pet owners know little to nothing about pet cancer symptoms. To help combat the issue, Blue Buffalo Foundation announced plans to raise more than $3 million this year to help find a cure for feline and canine cancer. The foundation's annual consumer education program and Pet Cancer Awareness fundraising campaign, which have recognized May as Pet Cancer Awareness Month since 2004, provides financial support for families affected by pet cancer and funding for research at veterinary colleges and nonprofit organizations across the country. In October last year, the foundation awarded the Animal Cancer Foundation a $1 million research grant to launch the Canine Cancer Genome Project, which maps the tumor genomes of the most common cancers in dogs. "Everyone has been touched by human or pet cancer at some point," said Gerald Post, DVM, MEM, DACVIM (Oncology) and chief medical officer at The Veterinary Cancer Center in Norwalk, Conn. "For our loved ones, the pace of cancer research and the development of innovative treatment is too slow." For more …
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Animal Cancer Foundation receives $1 million for canine cancer genome projectNovember 8, 2017 The Animal Cancer Foundation (ACF), a national nonprofit organization that supports comparative oncology research that studies the similarities between cancers in people and pets to help find cures for both, has received a $1 million dollar donation from the Blue Buffalo Foundation. The grant will provide funding for the Canine Cancer Genome Project (CCGP), which will map the tumor genomes of the most common canine cancers. Understanding the genetic makeup of canine cancer tumors, and comparing their genetic makeup to those of people with cancer, will allow researchers to discover additional targeted drug therapies and the least toxic doses of those therapies that are most effective in curing the individual, whether canine or human, according to ACF. The initiative arose as a result of a review conducted in 2015 by the Institute of Medicine of the National Academy of Science and supported in part by ACF that highlighted the value of comparative oncology and the inclusion of veterinary oncologists in accelerating cancer drug development. ACF has pledged to raise an additional $1 million dollars in support of the CCGP. The fundraising effort is supported by Blue Buffalo Foundation, which has partnered with …
